MRK vs QGEN
Merck & Co. vs Qiagen N.V. — AI-powered side-by-side comparison
| Metric | MRK | QGEN |
|---|
| AI Score |
70
|
64
|
| Price |
$130.34
|
$42.66
|
| P/E Ratio |
103.53×
|
21.87×
|
| ROE |
34.7%
|
11.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
75.4%
|
61.7%
|
| Debt / Equity |
1.29×
|
0.49×
|
| Dividend Yield |
2.6%
|
6.2%
|
| RSI (14) |
64.5
|
57.5
|
| Beta |
0.207
|
0.62
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for MRK versus QGEN.
MRK leads by 6 points.
MRK scores 70/100 (Buy) versus QGEN at 64/100 (Buy).
MRK Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
QGEN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- EPS growing 341.4% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro